ArticleJournal of robotic surgery2025
Comparative study between Hugo™ RAS and intuitive da Vinci Xi systems in different gynecologic surgeries: a single-institution perspective study.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Da VinciSurgical endoscopy · 2026Observational
- A systematic scoping review of Hugo™ RAS (robot-assisted surgery) docking concordance in gynecologic robotic surgery.Journal of robotic surgery · 2026Article
- Robot-assisted sacrocolpopexy using the Hugo-RAS system: initial series with no experience in robotic surgery.Gynecology and pelvic medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective is to compare the feasibility, safety, and complications of the novel robot-assisted system Hugo™ RAS to the established Intuitive da Vinci Xi system in different gynecologic surgeries. This is a retrospective and propensity score-matching study conducted at a tertiary teaching hospital. The participants were women with various indications for gynecologic surgery who underwent robotic procedures. The results of our first 40 cases of gynecologic procedures performed with Hugo™ RAS were compared to those of a 1:3 propensity-matched cohort using the da Vinci Xi system. Length of hospital stay, blood loss, surgical time, console time, and perioperative complications were the main outcome measures. There were no differences in the length of hospital stay, blood loss, and complication rates between the novel Hugo™ RAS and da Vinci Xi system in different gynecologic procedures. However, the surgical time was longer with Hugo™ RAS in the staging of endometrial cancer. The Hugo™ RAS is a feasible and safe robotic platform for different indications in gynecologic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.